stockrowInsulet Corporation (PODD) vs Zimmer Biomet Holdings, Inc. (ZBH)
- Insulet Corporation PODD 145.88 −6.56%
- Zimmer Biomet Holdings, Inc. ZBH 106.07 −0.73%
Insulet Corporation and Zimmer Biomet Holdings, Inc. are both Medical Devices companies. Zimmer Biomet Holdings, Inc. is the larger, with a market value of $20.4B against $10.8B — 1.9× the size. Insulet Corporation trades at the lower P/E: 25.2× against 26.9×. Insulet Corporation grew revenue faster over the last twelve months: 26.5% against 6.98%. Insulet Corporation has the higher net margin (13.5% vs 8.95%) and the higher return on invested capital (18.8% vs 3.66%). Across the 22 metrics below, Insulet Corporation leads on 13 and Zimmer Biomet Holdings, Inc. on 9.
Valuation
Profitability
| Metric | PODD | ZBH | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.88% | 69.68% | 57.76% |
| Operating margin | 18.43% | 13.55% | (15.07%) |
| Net margin | 13.45% | 8.95% | (14.45%) |
| Free cash flow margin | 8.15% | 13.02% | (3.88%) |
| Return on equity | 28.94% | 6.02% | (10.35%) |
| Return on assets | 13.31% | 3.26% | (17.26%) |
| Return on invested capital | 18.77% | 3.66% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack